Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Evaluation of Chemosensitivity for Low-risk Stage II/III Rectal Cancer

NCT03666442 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT03666442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03666442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Evaluation of Chemosensitivity for Low-risk Stage II/III Rectal Cancer
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2018
Completion date
January 1, 2022
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer